Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 DSM, AC Immune Partner on AD Antibody | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

DSM, AC Immune Partner on AD Antibody

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

DSM Biologics and AC Immune SA have signed a Memorandum of Understanding in which the parties have agreed that DSM will be the development and manufacturing partner for AC Immune’s monoclonal antibody against Alzheimer’s disease. The development and manufacturing activities will be done in DSM Biologics’ FDA-approved manufacturing facility in Groningen, The Netherlands. AC Immune is based in Lausanne, Switzerland.

“After an intensive market analysis we have decided to choose DSM as our partner for the production of AC Immune’s conformation-specific monoclonal Alzheimer’s antibody, ACI-01-Ab7, based on the best quality to cost offerings by DSM,” said Andrea Pfeifer, chief executive officer of AC Immune.

“DSM Biologics is very exited to contribute to the development of AC Immune’s promising drug for treating Alzheimer’s disease and is looking forward to the mutually beneficial collaboration,” said Terry Novak, chief marketing officer, DSM Pharmaceutical Products.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters